Predicting both passive intestinal absorption and the dissociation constant toward albumin using the PAMPA technique

被引:21
作者
Bujard, Alban [1 ]
Sol, Marine [1 ]
Carrupt, Pierre-Alain [1 ]
Martel, Sophie [1 ]
机构
[1] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland
关键词
PAMPA; Passive permeability; Human serum albumin; Permeation coefficient; Constant of dissociation; MEMBRANE-PERMEABILITY ASSAY; PLASMA-PROTEIN BINDING; CAPILLARY ELECTROPHORESIS/FRONTAL ANALYSIS; HUMAN SERUM-ALBUMIN; HIGH-THROUGHPUT; DRUGS;
D O I
10.1016/j.ejps.2014.06.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The parallel artificial membrane permeability assay (PAMPA) is a high-throughput screening (HTS) method that is widely used to predict in vivo passive permeability through biological barriers, such as the skin, the blood brain barrier (BBB) and the gastrointestinal tract (GIT). The PAMPA technique has also been used to predict the dissociation constant (K-d) between a compound and human serum albumin (HSA) while disregarding passive permeability. Furthermore, the assay is based on the use of two separate 5-point kinetic experiments, which increases the analysis time. In the present study, we adapted the hexadecane membrane (HDM)-PAMPA assay to both predict passive gastrointestinal absorption via the permeability coefficient log P-e value and determine the K-d. Two assays were performed: one in the presence and one in the absence of HSA in the acceptor compartment. In the absence of HSA, log P-e values were determined after a 4-h incubation time, as originally described, but the dimethylsulfoxide (DMSO) percentage and pH were altered to be compatible with the protein. In parallel, a second PAMPA assay was performed in the presence of HSA during a 16-h incubation period. By adding HSA, a variation in the amount of compound crossing the membrane was observed compared to the permeability measured in the absence of HSA. The concentration of compound reaching the acceptor compartment in each case was used to determine both parameters (log P-e and log K-d) using numerical simulations, which highlighted the originality of this method because these calculations required only two endpoint measurements instead of a complete kinetic study. It should be noted that the amount of compound that reaches the acceptor compartment in the presence of HSA is modulated by complex dissociation in the receptor compartment. Only compounds that are moderately bound to albumin (-3 < log K-d [M] < 6) can be measured using this method. If compound permeability through the artificial membrane is low in the absence of HSA, the impact of complex formation/dissociation cannot be detected, and thus, log K-d cannot be determined for this class of compounds. Thirteen compounds with known K-d values were analyzed using this method, and the obtained K-d values were in agreement with those obtained using primarily the gold-standard equilibrium dialysis. A linear correlation with a determination coefficient (r(2)) equal to 0.88 was obtained. This assay utilizes a technique that is currently routinely used in industrial companies to obtain permeability measurements; moreover, this approach is fast (96-well plate format), economical and easy to handle. This assay uses protein freely in solution, which may be more relevant than embedded proteins in chromatographic systems, for example. Finally, this method can be adapted to numerous other highly stable proteins. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 35 条
[21]  
Myszka, 2000, Pharm Sci Technol Today, V3, P310
[22]   Parallel artificial membrane permeability assay: A new membrane for the fast prediction of passive human skin permeability [J].
Ottaviani, Giorgio ;
Martel, Sophie ;
Carrupt, Pierre-Alain .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (13) :3948-3954
[23]  
Peters T.J., 1996, All About Albumin. Biochemistry, Genetics And Medical Applications., P76, DOI [DOI 10.1016/B978-012552110-9/50005-2, 10.1016/B978-012552110-9/50005-2]
[24]   High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE [J].
Rich, RL ;
Day, YSN ;
Morton, TA ;
Myszka, DG .
ANALYTICAL BIOCHEMISTRY, 2001, 296 (02) :197-207
[25]   Skin-PAMPA: A new method for fast prediction of skin penetration [J].
Sinko, Balint ;
Garrigues, Teresa M. ;
Balogh, Gyoergy T. ;
Nagy, Zsombor K. ;
Tsinman, Oksana ;
Avdeef, Alex ;
Takacs-Novak, Krisztina .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 45 (05) :698-707
[26]   H+-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine [J].
Thwaites, David T. ;
Anderson, Catriona M. H. .
EXPERIMENTAL PHYSIOLOGY, 2007, 92 (04) :603-619
[27]   Which in vitro screens guide the prediction of oral absorption and volume of distribution? [J].
van de Waterbeemd, H .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (03) :162-166
[28]   Global analytical strategy to measure drug-plasma protein interactions: from high-throughput to in-depth analysis [J].
Vuignier, Karine ;
Veuthey, Jean-Luc ;
Carrupt, Pierre-Alain ;
Schappler, Julie .
DRUG DISCOVERY TODAY, 2013, 18 (21-22) :1030-1034
[29]   High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions [J].
Vuignier, Karine ;
Guillarme, Davy ;
Veuthey, Jean-Luc ;
Carrupt, Pierre-Alain ;
Schappler, Julie .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 74 :205-212
[30]   Characterization of drug-protein interactions by capillary electrophoresis hyphenated to mass spectrometry [J].
Vuignier, Karine ;
Veuthey, Jean-Luc ;
Carrupt, Pierre-Alain ;
Schappler, Julie .
ELECTROPHORESIS, 2012, 33 (22) :3306-3315